Primary vitreoretinal lymphoma : prevalence, impact, and management challenges
Primary vitreoretinal lymphoma (PVRL) is a rare and potentially fatal intraocular malignancy. More than half of PVRL cases eventually involve the central nervous system (CNS). PVRL frequently masquerades as chronic uveitis. Advanced imaging tests, such as optical coherence tomography and fundus autofluorescence, have been applied in the diagnosis of PVRL. Histology and immunohistochemistry, in combination with molecular tests and IL-10 analysis, have been demonstrated as reliable in diagnosing PVRL. Mortality is high in patients with PVRL associated with CNS involvement, and relapses are common. The use of systemic chemotherapy in addition to the local therapies has proved to extend the mean survival time of these patients. Local therapies, including intravitreal injections of methotrexate and/or rituximab and low-dose radiotherapy to the eye, have been shown to be extremely effective in controlling intraocular lymphoma.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Clinical ophthalmology (Auckland, N.Z.) - 13(2019) vom: 25., Seite 353-364 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Venkatesh, Ramesh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CNS lymphoma |
|---|
| Anmerkungen: |
Date Revised 01.10.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.2147/OPTH.S159014 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM294821996 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM294821996 | ||
| 003 | DE-627 | ||
| 005 | 20231225082322.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2147/OPTH.S159014 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0982.xml |
| 035 | |a (DE-627)NLM294821996 | ||
| 035 | |a (NLM)30858685 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Venkatesh, Ramesh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Primary vitreoretinal lymphoma |b prevalence, impact, and management challenges |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.10.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Primary vitreoretinal lymphoma (PVRL) is a rare and potentially fatal intraocular malignancy. More than half of PVRL cases eventually involve the central nervous system (CNS). PVRL frequently masquerades as chronic uveitis. Advanced imaging tests, such as optical coherence tomography and fundus autofluorescence, have been applied in the diagnosis of PVRL. Histology and immunohistochemistry, in combination with molecular tests and IL-10 analysis, have been demonstrated as reliable in diagnosing PVRL. Mortality is high in patients with PVRL associated with CNS involvement, and relapses are common. The use of systemic chemotherapy in addition to the local therapies has proved to extend the mean survival time of these patients. Local therapies, including intravitreal injections of methotrexate and/or rituximab and low-dose radiotherapy to the eye, have been shown to be extremely effective in controlling intraocular lymphoma | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a CNS lymphoma | |
| 650 | 4 | |a investigations | |
| 650 | 4 | |a malignancy | |
| 650 | 4 | |a ocular tumor | |
| 650 | 4 | |a prognosis | |
| 650 | 4 | |a treatment | |
| 700 | 1 | |a Bavaharan, Bharathi |e verfasserin |4 aut | |
| 700 | 1 | |a Mahendradas, Padmamalini |e verfasserin |4 aut | |
| 700 | 1 | |a Yadav, Naresh Kumar |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical ophthalmology (Auckland, N.Z.) |d 2007 |g 13(2019) vom: 25., Seite 353-364 |w (DE-627)NLM186998104 |x 1177-5467 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2019 |g day:25 |g pages:353-364 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2147/OPTH.S159014 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2019 |b 25 |h 353-364 | ||